Multiple Assemblies exist for SMTL entry 6usx
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer; X-RAY DIFFRACTION 2.27 Å

	SMTL ID 6usx.1 Ligands GUANOSINE-5'-DIPHOSPHATE; MAGNESIUM ION; 1-{4-[2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl}propan-1-one Polypeptides GTPase KRas Oligo-state monomer
	SMTL ID 6usx.2 Ligands GUANOSINE-5'-DIPHOSPHATE; MAGNESIUM ION; 1-{4-[2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl}propan-1-one Polypeptides GTPase KRas Oligo-state monomer